Evidence map›Paper›PMID 33050090›Full record

ArticleSensors (Basel, Switzerland)2020

Influence of Nivolumab for Intercellular Adhesion Force between a T Cell and a Cancer Cell Evaluated by AFM Force Spectroscopy.

Hyonchol Kim, Kenta Ishibashi, Masumi Iijima, Shun'ichi Kuroda, Chikashi Nakamura

Open access · goldAbstract readLetter
In one paragraph

Article in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Hyonchol KimCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8565, Japan.ORCID 0000-0002-1786-648X
Kenta IshibashiGraduate School of Engineering, Tokyo University of Agriculture and Technology, Tokyo 184-8588, Japan.
Masumi IijimaDepartment of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture, Tokyo 156-8502, Japan.
Shun'ichi KurodaDepartment of Biomolecular Science and Reaction, The Institute of Scientific and Industrial Research, Osaka University, Osaka 567-0047, Japan.
Chikashi NakamuraCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8565, Japan.
National Institute of Advanced Industrial Science and Technology · JPThe University of Osaka · JPTokyo University of Agriculture · JPTokyo University of Agriculture and Technology · JP

Funding

Japan Society for the Promotion of Science 20H02597Japan Society for the Promotion of Science Japan-Korea basic scientific cooperation program
6 · The paper itself

Abstract

The influence of nivolumab on intercellular adhesion forces between T cells and cancer cells was evaluated quantitatively using atomic force microscopy (AFM). Two model T cells, one expressing high levels of programmed cell death protein 1 (PD-1) (PD-1

Indexed as

Microscopy, Atomic ForceB7-H1 AntigenCell AdhesionHumansJurkat CellsMCF-7 CellsNivolumabProgrammed Cell Death 1 ReceptorSpectrum AnalysisT-LymphocytesB7-H1 AntigenCD274 protein, humanNivolumabPDCD1 protein, humanProgrammed Cell Death 1 Receptoratomic force microscopycell adhesionmicrocupnivolumabPD-1PD-L1

Identifiers

PMID33050090
PMCPMC7582537
OpenAlexW3092311397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.